CRR_Call Tracker

Text/HTML

Text/HTML

ValueProductView

ValueProductPastPerformance

Company NameReco DateReco PriceExit PriceExit Date% ReturnIn days
ITC Ltd. 28/12/2023464.20487.5002/01/2025 5.02% 1 yrs
Britannia Industries Ltd. 27/07/20234,875.805,028.2512/11/2024 3.13% 1 yrs
JSW Steel Ltd. 22/02/2024826.951,003.0026/09/2024 21.29% 217 days
Bajaj Auto Ltd. 22/08/20249,910.0011,930.0017/09/2024 20.38% 26 days
Dr. Reddy's Laboratories Ltd. 26/10/20235,429.306,536.0005/07/2024 20.38% 253 days
Shriram Finance Ltd. 25/04/20242,430.102,955.0028/06/2024 21.60% 64 days
Coal India Ltd. 25/01/2024389.50501.6022/05/2024 28.78% 118 days
Infosys Ltd. 27/10/20221,522.601,411.6019/04/2024 -7.29% 1 yrs
State Bank Of India 25/05/2023581.30782.0505/03/2024 34.53% 285 days
The Indian Hotels Company Ltd. 24/08/2023401.85517.9007/02/2024 28.88% 167 days

CRR_MVC_PastPerformance

Text/HTML

Our Other Trader Products

EasyDNNNews

Fundamental Analysis
Ninad Ramdasi

Fundamental Analysis

AMRUTANJAN HEALTH CARE LTD.

Ticker : 590006 
BUY : Rs 600 
Target : Rs 670

Amrutanjan Health Care Limited is engaged in the manufacturing of Ayurvedic pain balms and beverages. The company specialises in Ayurvedic balm for headaches, cold & cough. The segments of the company include over the counter (OTC) products, beverages, chemicals, and others. On the standalone quarterly front, the company recorded net sales of Rs 100.10 crore for Q3FY21, which is an increase of 20.96 per cent from its net sales of Rs 82.75 crore reported for Q3FY20. The operating profit jumped substantially to Rs 29.03 crore in Q3FY21 from Rs 13.87 crore posted in Q3FY20. The net profit was reported at Rs 20.98 crore in Q3FY21 from Rs 9.49 crore in Q3FY21, recording handsome gains. The demand for its core products namely balms & women's hygiene (Comfy) also witnessed a positive trend. The company is also focussing on expanding and strengthening its beverage business. Hence, we recommend BUY.

Previous Article Technicals Analysis
Next Article Sentiment Indicators
Print
296 Rate this article:
No rating
Please login or register to post comments.

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR